ATRA - CIK 0001604464
The table below shows Atara Biotherapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.48M | $25.03M | $25.84M | $92.94M | $106.08M | $200.40M |
| Short-term investments | $0.00 | $17.47M | $25.88M | $149.88M | $264.98M | $300.25M |
| Receivables | $1.25M | $1.48M | $34.11M | $40.22M | $986.00K | $1.25M |
| Inventory | $0.00 | $10.65M | $9.71M | $1.59M | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $12.21M |
| $64.89M |
| $101.87M |
| $295.08M |
| $384.62M |
| $523.27M |
| Property, plant & equipment | $73.00K | $1.29M | $3.86M | $6.30M | $53.78M | $50.52M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $20.23M | $109.10M | $165.50M | $376.42M | $468.13M | $588.12M |
| Accounts payable | $127.00K | $4.37M | $3.68M | $6.87M | $17.37M | $7.12M |
| Total current liabilities | $14.92M | $134.57M | $142.23M | $78.92M | $105.79M | $82.90M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $58.74M | $206.38M | $264.74M | $249.78M | $188.51M | $125.78M |
| Retained earnings | -$2.02B | -$2.05B | -$1.97B | -$1.69B | -$1.46B | -$1.12B |
| Total equity | -$38.50M | -$97.28M | -$99.23M | $126.64M | $279.61M | $462.34M |